Neurogene Inc. (NGNE)
NASDAQ: NGNE · IEX Real-Time Price · USD
29.96
+0.09 (0.30%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Neurogene Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
00000250000
Upgrade
Gross Profit
00000250000
Upgrade
Selling, General & Admin
11.199.0121.5417.2118.8315.8414.859.265.544.3
Upgrade
Research & Development
44.3947.5139.1624.344.4241.7936.2728.3815.818.08
Upgrade
Other Operating Expenses
000-7.8347.7200000
Upgrade
Operating Expenses
55.5856.5260.733.7370.9657.6251.1237.6521.3422.38
Upgrade
Operating Income
-55.58-56.52-60.7-33.73-70.96-32.62-51.12-37.65-21.34-22.38
Upgrade
Interest Expense / Income
0.01000000000.45
Upgrade
Other Expense / Income
-19.28-1.33-0.01-0.45-1.52-1.04-0.94-0.640.521.2
Upgrade
Pretax Income
-36.32-55.19-60.69-33.28-69.44-31.59-50.18-37-21.86-24.03
Upgrade
Net Income
-36.32-55.19-60.69-33.28-69.44-31.59-50.18-37-21.86-24.03
Upgrade
Shares Outstanding (Basic)
0033111110
Upgrade
Shares Outstanding (Diluted)
5033111110
Upgrade
Shares Change
1080.37%-85.66%6.21%91.73%14.93%0.30%24.12%49.50%45.81%2772.47%
Upgrade
EPS (Basic)
27.76-139.88-22.00-12.80-51.40-26.80-42.80-39.20-34.60-55.00
Upgrade
EPS (Diluted)
2.93-139.88-22.00-12.80-51.40-26.80-42.80-39.20-34.60-55.00
Upgrade
Free Cash Flow
-51.74-55.05-50.82-26.79-16.27-31.63-45.21-30.94-20.29-17.57
Upgrade
Free Cash Flow Per Share
-105.20-139.54-18.47-10.34-12.04-26.89-38.56-32.75-32.12-40.55
Upgrade
Gross Margin
-----100.00%----
Upgrade
Operating Margin
------130.50%----
Upgrade
Profit Margin
------126.34%----
Upgrade
Free Cash Flow Margin
------126.50%----
Upgrade
EBITDA
-32.35-51.38-58.42-31.46-68.91-31.29-49.82-37-21.86-23.58
Upgrade
EBITDA Margin
------125.17%----
Upgrade
Depreciation & Amortization
3.963.812.281.820.530.290.36000
Upgrade
EBIT
-36.31-55.19-60.69-33.28-69.44-31.58-50.18-37-21.86-23.58
Upgrade
EBIT Margin
------126.32%----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).